Alex Bataller, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the unmet needs in acute myeloid leukemia (AML), including treating patients with TP53 mutations and developing effective maintenance therapies to prevent relapse after transplant. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.